🇺🇸 FDA
Pipeline program

CKD-495 75mg

A74_02AG/CG1904

Phase 3 small_molecule completed

Quick answer

CKD-495 75mg for Gastritis is a Phase 3 program (small_molecule) at Hong Kong Baptist University with 1 ClinicalTrials.gov record(s).

Program details

Company
Hong Kong Baptist University
Indication
Gastritis
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials